Seaport Therapeutics Reports Q1 GAAP EPS of -$10.34
Seaport Therapeutics (NASDAQ:SPTX) reported a first-quarter GAAP earnings per share loss of $10.34 for the period ending March 31, 2026. The company held cash and investments totaling $212.6 million as of that date and subsequently raised an additional $260.0 million through its IPO.
Topics: financials ipo